To define and measure the global top ten medical device technologies mainly by their high growth technologies, and also by products and applications wherever applicable
To focus the macro markets and micro markets specifically on the basis of products, applications, and recent technologies which promise a huge growth potential in future
To identify the key micro markets which are set to yield high profit margin, and expected to grow exponentially in the coming years, and their subsequent drivers for the growth
To identify market trends, gaps and opportunities for all the stakeholders
To strategically analyze the market structure and competitive landscape profiling in detail for all the top companies in all the micro markets of the identified top ten medical device technologies
MARKET COVERED
In the entire medical device industry, continuous innovations keep on happening, thus leading to radical transformation in patient care. Here in this report, we have tried identifying the sectors with the most important developments affecting patient care, clinical outcome, product development, and the device industry as a whole. Though we have tried covering all the important technologies under our report, but we might have missed few other equally important technologies as well, because the scope of the report was limited to ten technologies only. But, still we have covered almost the entire medical device market as a whole.
This report will analyze the market potential for the global top ten medical device technologies. The technologies are selected on the basis of the following factors in prioritized order:
Technologies which cover a major share of the entire medical device market: Under each of these categories, the individual high growth micro technology markets are identified
Technologies foreseeing a huge growth potential in coming four to five years (mainly the technologies having an annual growth rate of more than 10%)
The technologies being covered in the study are:
Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
Bio-implants (neurostimulation and others)
Tele-medicines
The existing studies and third-party market reports do not provide a comprehensive understanding of the global top ten medical device technologies market. The critical markets within this broader field are also not analyzed. This report not only provides a full market estimate of global top ten medical device technologies market; it also gives a detailed analysis of its most critical micro markets, which have so far remained unexplored.
In addition to the comprehensive information on the macro markets, it also covers the comparative analysis of the following technologies, which will provide a clear view to the stakeholders about the lifecycle and market attractiveness of each of these technologies:
Technologies which were existing previously in place of the current technology
Current technologies existing in the market
Future alternatives to these technologies
REPORT DESCRIPTION
The report gives a full breakdown of the entire global top ten medical device technologies market on the basis of products, applications, technology, and end-users. Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook.
The report features more than 100 tables that give a complete insight into the market, along with 60 competitive company profiles. All market tables will be categorized by geographic region, product, application, technology, and end-user categories.
The report highlights strategic issues that how the global top ten medical device technologies will be able to cover up the already existing older technologies. This will also include consolidating strategy, new product development, competitive positioning, gap analysis and identification of opportunities and challenges. Niche opportunities are identified for both product and service sub-segments within these identified global top ten medical device technologies.
STAKEHOLDERS
The intended audience includes all the stakeholders of the global top ten medical device technologies market-
Medical Device Manufacturers: The report defines the market size and forecast up to the year 2014 for each of the micro markets under the individual global top ten medical device technologies market. It also provides technology developments, competitive landscape and the profiles of the key players existing in the industry
Hospital Surgical Departments: The report provides market information on new technologies and their market potential for the surgical devices in the medical devices market
Clinical Research Firms: The report provides a comparative analysis of the various technologies which were prevailing in the past, the existing technologies, and the technologies which will replace these existing technologies
Business research and consulting service providers: Business research and consulting firms will need this report to get the market and geographic data points for specific micro markets; and to identify the major players and their competitive landscape in this industry.
1.Chapter one – introduction
2.Chapter two – summary
3.Chapter three – market overview
3.1.Evolution of medical device technologies
3.2.Defining the top ten medical device technologies market
3.3.Patients' drift towards better quality of life leading to adoption of innovative medical devices
3.4.Aging population over 65 dictates the market for medical devices
3.5.Opportunity for medical device technologies lies in the less developed countries
3.6.Extensive product recalls is a major challenge for the medical device industry
4.Chapter four – diagnostic imaging
4.1.Market drivers
4.1.1.Emergence of new technology in diagnostic imaging
4.1.2.Expansion in the applications of diagnostic imaging
4.1.3.Aging demographics
4.1.4.Preventative healthcare in demand
4.1.5.Expansion of testing technologies coverage
4.2.Restraints
4.2.1.Slowdown in demand for medical imaging equipments due to economic turmoil
4.2.2.Regulatory body initiatives to tighten the healthcare cost are slowing the sales of these devices
4.3.Competitive landscape
4.4.Mri systems
4.4.1.Market drivers
4.4.1.1.Wide variety of application
4.4.1.2.Improvement in telsa strength
4.4.2.Competitive landscape
4.5.Ultrasound systems
4.5.1.Market drivers
4.5.1.1.Untapped demand of emerging market driving the growth of ultra sound system market
4.5.1.2.Refurbished equipment market for ultrasound system is booming
4.5.1.3.Increased use of ultrasound by emergency medical services and non-radiologists
4.5.2.Restraints
4.5.2.1.Saturation in core market limiting the sales for new ultrasound system
4.5.2.2.Lack of clear and adequate reimbursement for new ultrasound capabilities
4.5.3.Competitive landscape
4.6.X-ray systems
4.6.1.Market drivers
4.6.1.1.Finer image quality
4.6.2.Restraints
4.6.2.1.Other advanced diagnostic imaging technologies hindering the growth of x-ray market
4.6.2.2.Cost issues affecting the further spread of x-ray market
4.6.3.Competitive landscape
4.6.3.1.Merges and acquisitions for x-ray systems market
4.6.3.2.Other developments for x-ray systems
4.7.Mammography equipments
4.7.1.Market drivers
4.7.1.1.Increase in demand of digital mammography enhancing the growth opportunities for the mammography equipment due to advanced technology
4.7.1.2.Favorable reimbursement scenario boosting the demand for the mammography equipment
4.8.Tomography equipments
4.8.1.Market drivers
4.8.1.1.Introduction of higher slice ct scanner promising growth opportunities in the tomography market
4.8.1.2.Increase in angiogram ct application is driving the growth of the market
4.8.1.3.Optical coherence tomography (oct) is the new optics technology creating a significant niche in ophthalmology
4.8.2.Restraints
4.8.2.1.Shift from a slice count basis to detector coverage
4.8.2.2.Mri moving ahead from ct scan
4.8.3.Competitive development
4.9.Nuclear imaging equipments
4.9.1.Nuclear imaging getting widely accepted for early diagnosis of cardiology, cancer and neurological disorder
4.9.2.Hybrid imaging modalities capturing the nuclear imaging equipments market
4.9.3.Competitive landscape
4.9.4.Other developments
4.10.Interventional radiology
4.10.1.Market drivers
4.10.1.1.Advances in medical instrumentation and in radiological imaging technology are driving the market for interventional radiology procedures
4.10.1.2. Minimally invasive imaging procedures cardiac interventional and radiology vascular interventional radiology are gaining popularity
4.10.2.Restraints
4.10.2.1.Financial limitation put a stop to capital investment by the hospitals for interventional radiology
4.10.2.2.Lack of professional radiologist affecting the interventional radiology market
4.10.3.Competitive landscape
4.11.Capsule endoscopy
4.11.1.Market drivers
4.11.1.1.Application of capsule endoscopy for gastrointestinal ailments diagnosis is picking up due to innovative design for colonic indications
4.11.1.2.Favorable move from fda further clearing the growth path for capsule endoscopy
4.11.2.Competitive landscape
4.12.Lasers – imaging
4.12.1.Market drivers
4.12.1.1.Reasonably priced lasers has marked its presence in medical fraternity
4.12.1.2.A number of benefits expand the scope and opportunities for the laser technology
5.Chapter five – Drug delivery devices
5.1.Inhalation systems
5.1.1.Market drivers
5.1.2.Competitive landscape
5.2.Infusion system
5.2.1.Competitive landscape
5.3.Needle-free injection/transdermal systems
5.3.1.Market drivers
5.3.2.Restraints
5.3.3.Competitive landscape
6.Chapter six – Medical diagnostics
6.1.Market drivers
6.1.1.Popularity of point of care (poc) and home health care driving the market for medical diagnostic
6.1.2.The medical diagnostic is expected to expand due to rise in demand for genetic testing, esoteric testing and high end molecular diagnostic testing
6.2.Restraints
6.2.1.Factors such as economic slowdown, drugs abuse testing, test validation has affected the market momentum as confusion prevails among common public
6.3.Biosensors
6.3.1.Market drivers
6.3.1.1.Increase in biosensor usage due to multiple applications leading to market growth of biosensors
6.3.1.2.Population explosion and unhealthy lifestyles leading to the explosive demand for biosensors
6.3.1.3.Miniaturization key to success for biosensors
6.3.2.Restraints
6.3.2.1.High cost involved in r&d of biosensors
6.4.In vitro diagnostic (ivd)
6.4.1.Market drivers
6.4.1.1.Demand for the ivd in emerging markets
6.4.1.2.Increase in worldwide aging population needing diagnostic services
6.4.1.3.Increase in accessibility health care services by people
6.4.2.Restraints
6.4.2.1.Consolidation of hospital and commercial laboratories market and price pressure affecting the market growth
6.4.2.2.Intense scrutiny by food and drug authority (fda) on ivd diagnostic market restraining the market
6.5.Proteomics for molecular diagnostics
6.5.1.Market drivers
6.5.1.1.Proteomics: serving an opportunity for new drug and diagnostic market in terms of targeting more diseases
6.5.1.2.Proteomics is a tool for analysis of pharmacological profiling, toxicity testing and drug’s effectiveness
6.5.1.3.Enables detection of non communicable diseases
6.5.2.Restraints
6.5.2.1.The structuring of proteins needs expensive tools and machines leading to lower adoption rates
6.5.2.2.Cost & reimbursement complexities emerging as major obstacles for the market
6.5.2.3.Lack of technologies to speed up validation process
6.5.3.Competitive landscape
6.5.3.1.New product launch
6.6.Nanotechnology for molecular diagnostics
6.6.1.Market drivers
6.6.1.1.Increase in demand of genetic screening, preimplantation screening and for the diagnosis of infectious diseases
6.6.2.Opportunity
6.6.2.1.Nanotechnology for cancer diagnostics showcasing promising future
6.6.3.Restraint
6.6.3.1.Lack of commercialization of nanotechnology medical devices
6.6.4.Competitive landscape
6.6.4.1.New product launch
6.6.4.2.Other developments
6.7.Pcr (polymerase chain reaction)
6.7.1.Market drivers
6.7.1.1.Potential to replace the conventional tests for infectious diseases, cancer diagnosis and genetic diseases
6.7.1.2.Real- time pcr instrumentation clearance from fda is strengthening the clinical diagnostic market
6.7.2.Restraint
6.7.2.1.New technology, qpcr is replacing conventional pcr market
6.7.2.2.Price sensitivity of pcr technology is area of concern for the end users
6.8.Arrays
6.8.1.Market drivers
6.8.1.1.Demand for protein array on rise as it is facilitating drug discovery
6.8.1.2.Classification of cancers done by micro array technology helping doctors to give appropriate treatment to the patients
6.8.1.3.Minimal use of materials makes microarrays an inexpensive technology
7.Chapter seven – mobility aid technologies
7.1.Market drivers
7.1.1.Aging population with mobility issues driving the market for mobility aid technology
7.1.2.Demand for more independent life and assistance free daily living
7.1.3.Popularization of physically challenged sports and recreation program
7.1.4.Emergence of robotics technology in assistive device market
7.2.Restraints
7.2.1.Manual wheel chairs not suitable for people who suffer impairment of upper limbs
7.3.Competitive landscape
7.4.Global mobility aid technologies market by product types
7.4.1.Wheelchairs and related devices
7.4.1.1.Market drivers
7.4.1.1.1.Rise in population suffering from arthritis, arthrogryposis, osteoporosis etc.
7.4.1.1.2.Wide range of designs, materials, and configurations available in the market attracts users looking for the comfort
7.4.1.1.3.Increase in demand for power wheel chair because of more efficient mobility
7.4.1.2.Restraints
7.4.1.2.1.Power dependence by powered wheel chair
7.4.1.2.2.Powered assist device more costly and less portable then manual wheel chair
7.4.1.2.3.Reimbursement issues with the powered wheelchairs
7.4.1.3.Competitive landscape
7.4.1.4.Manual wheelchairs
7.5.Global mobility aid device market by technology
7.5.1.Robotics
7.5.2.Non robotics
7.5.3.Walking-assist devices
7.5.3.1.Market drivers
7.5.3.1.1.Changes in social trends like single parent and small family size creating demand for walking assist devices
7.5.3.1.2.More cases of cerebral palsy leading demand for more walking assist device to improve quality life
7.5.3.2.Restraints
8.Chapter eight – minimal invasive/non invasive surgery
8.1.Market drivers
8.1.1.Increase in aging population (65+) boosts the demand for surgeries
8.1.2.Increase in demand of less risky operating methods
8.1.3.Pressure to reduce heath care cost increases the market for minimal invasive surgery
8.1.4.Lesser hospitalization period compared to conventional surgeries
8.1.5.Higher rate of acceptance of minimal invasive surgery techniques
8.1.6.Less painful and quicker recovery method of surgery compared open surgeries
8.2.Restraints
8.2.1.Limited number of surgeries performed with minimal invasive technique
8.2.2.Special training and equipment is required to perform minimal invasive surgery
8.3.Opportunities
8.3.1.Huge market size attracting new entrants in minimal invasive market
8.3.2.Physicians are setting a strong foundation for the future of minimal invasive surgery market
8.4.Stent
8.4.1.Market drivers
8.4.1.1.Rise in cardio vascular diseases and access to conventional as well as hybrid cardiovascular procedures
8.4.1.2.Rise in demand of minimal invasive heart surgeries
8.4.1.3.Increase in number of obese and diabetic population world wide
8.5.Medical robotics
8.5.1.Market drivers
8.5.1.1.Improved surgical results attracting more patients
8.5.1.2.Shortening of surgical time is increasing the revenue of hospitals
8.5.1.3.Improved surgeon ergonomics brings in accuracy
8.5.1.4.Cost effectiveness
8.5.2.Restraints
8.5.2.1.Lack of human touch and intelligence
8.5.3.Competitive landscape
8.6.Light amplification by stimulated emission of radiation (lasers)
8.6.1.Market drivers
8.6.1.1.Growing awareness among people about laser technology has led to increased acceptance
8.6.1.2.Rise in age-related diseases likely to enhance sales
8.6.2.Developments
8.7.Bariartic surgery
8.7.1.Market drivers
8.7.1.1.Growing number of overweight and obese population has increased the demand for surgeries
8.7.1.2.Technological innovation with better and faster patient outcomes attracts patients
8.7.1.3.Rising obesity among children expands the patient base
8.7.1.4.Increase in awareness of obesity as a dangerous disease
9.Chapter nine – micro- fluids chip and mems
9.1.Market drivers
9.1.1.Cost effective complex analysis system can be developed on a microfluidic (mf) chip
9.1.2.Mf chip acts as an essential tool for mass spectrometry
9.1.3.Complete automation in a single device leads to reduction in accidental loss of reagents
9.1.4.Microchips enable greater speed & higher quality of output
9.1.5.The minimal requirement of samples results in cost reduction
9.2.Restraints
9.2.1.Microfluidic chip technology unable to mix fluids on the chips in an effective manner, making them less favorable for analysis of complex fluids
9.2.2.Lack of commercialization with respect to mems technology
9.3.Miniature medical pressure sensors
9.4.Biochips
9.4.1.Market drivers
9.4.2.Restraints
9.4.3.Competitive landscape
9.4.3.1.Other developments
9.5.Dna chips
9.5.1.Advances in microfluidics has strengthen the commercial potential of loc
9.5.2.The demand for reduced sample size and reagent cost for new drug discovery has been major targeted areas of loc
9.5.3.High development cost hampers the penetration of loc market
9.6.Protein chips
9.6.1.Competitive landscape
9.6.1.1.Mergers and acquisitions for protein chips
9.6.1.2.Other developments for protein chips
10.Chapter ten – Non invasive monitoring
10.1.Biosensors
10.1.1.Wide scale acceptability of biosensors leading to deep penetration in the diagnostic market
10.1.2.High cost involved in wide scale commercialization of biosensors restraining the growth of the market
10.1.3.Continuous glucose monitoring
10.1.3.1.Market drivers
10.1.3.1.1.Emergence of diabetes as an epidemic worldwide has spurt the demand for continuous glucose monitoring
10.1.3.1.2.Convenient usage of non invasive continuous glucose monitoring facilitating the market growth of continuous glucose monitoring
11.Chapter eleven – Biomaterials
11.1.Increase in aging population with a surge in age related orthopedic conditions will increase the demand for biomaterials
11.2.Cost- containment strategy and high degree of regulatory scrutiny by government is affecting the european and u.s. Market
11.3.Applications of biomaterials
11.4.Bionic limbs
11.5.Competitive landscape
11.6.Bio-compatible materials
11.6.1.Market drivers
11.6.1.1.Advancements in nanotechnology will boost the performance of bio-compatible ceramics
11.6.1.2.Increase in demand of bio-compatible materials due to older population and demand from young people for highly functional requirements
11.6.2.Vulcanized silicon based materials
11.6.3.Joint replacement
11.6.3.1. Market drivers
11.6.3.1.1.Rise in prevalence and incidences of orthopedic diseases in aging population
11.6.3.1.2.Rise in the level of acceptability of bone grafts substitutes in wide range of application
11.6.3.2.Restraints
11.6.3.2.1.Rise in prices of titanium restraining the joint replacement market
11.6.3.2.2.Modification in reimbursement policies affecting the joint replacement surgeries will affect the components used in joint replacement as well as surgeries
11.7.Antimicrobial wound dressing
11.7.1.Market drivers
11.7.1.1.New products in anti microbial wound dressing are driving the growth potential of this market
11.7.1.2.Active demand of anti microbial wound dressing in the home health care
11.7.2.Restraints
11.7.2.1.Reluctance on part of physicians and nurses to adopt new products such that antimicrobial wound dressing
12.Chapter twelve – Bio-implants
12.1.Graft based implants
12.1.1.Market drivers
12.1.1.1.An increase in acceptance of graft based implants by medical practitioners
12.1.1.2.Cosmetic surgery is gearing up due to the desire of beautiful personality
12.1.2.Restraints
12.1.2.1.Expensive bone grafts
12.1.2.2.Less interest shown by doctors to adopt new technique like bone graft
12.2.Synthetic implants
12.2.1.Market drivers
12.2.1.1.Wide area of applications are driving the market of synthetic implants
12.2.1.2.Good bio-compatibility of synthetic implants is making them a safe choice for implants
12.2.2.Competitive landscape
12.2.3.Neurostimulation
12.2.3.1.Market drivers
12.2.3.1.1.Rise in the aging population above 60+ (age) boosts the demand for neurostimulation market
12.2.3.1.2.Increase in demand of less complicated operating methods and treatments
12.2.3.1.3.Lesser treatment period as compared to old conventional surgeries
12.2.3.1.4.Technological advancements
12.2.3.1.5.The use of implantable neurostimulation devices in the treatment of the neurodisorders is increasing
12.2.3.2.Restraints
12.2.3.2.1.Special expertise is required to perform neurostimulation related surgeries
12.2.3.3.Opportunities
12.2.3.3.1.Physicians and surgeons are setting strong foundation for the future neurostimulation treatment
12.2.3.3.2.Huge market size provides an opportunity for the growth of the market
12.2.3.4.Spinal cord stimulation (scs)
12.2.3.4.1.Market drivers
12.2.3.4.2.Opportunities
12.2.3.4.3.Competitive landscape
12.2.3.5.Sacral nerve stimulation (sns)
12.2.3.5.1.Market drivers
12.2.3.5.2.Opportunities
12.2.3.6.Vagus nerve stimulation (vns)
12.2.3.6.1.Market drivers
12.2.3.6.2.Opportunities
12.2.3.6.3.Competitive landscape
12.2.3.7.Deep brain stimulation systems
12.2.3.7.1.Market drivers
12.2.3.7.2.Restraints
12.2.3.7.3.Opportunity
12.2.3.7.4.Competitive landscape
13.Chapter thirteen – Tele-medicines
13.1.Hospitals
13.1.1.Inpatient
13.1.2.Outpatient
13.1.3.Telemedicine vital signals (clinical health care signals)
13.1.4.Telehealth
13.1.5.Telehome
13.1.6.Telehospital
13.2.Key playing fields in telemedicine
13.2.1.Market drivers
13.2.1.1.Changing healthcare paradigm – inevitable need for telemedicine
13.2.1.2.Increasing chronic diseases
13.2.1.3.The healthcare network has turned complex
13.2.1.4.Rising cost of home care
13.2.1.5.Increasing aging patients requiring daily care
13.2.1.6.Higher spending on it
13.2.1.7.Moving from treatment to early intervention
13.2.2.Restraints
13.2.2.1.Technical
13.2.2.2.Financial
13.2.2.2.1.Doubts on the self-sustaining ability of the telemedicine model
13.2.2.2.2.Reimbursement will decide the future of telemedicine
13.2.2.2.3.Lack of funding of telemedicine programs
13.2.3.Operational and social
13.2.3.1.Lack of training
13.2.3.2.Awareness and penetration
13.2.4.Telemedicine technology
13.2.4.1.Hardware
13.2.4.2.Software
13.2.4.3.Telecom and network
13.2.4.3.1.Telecom and networking market
13.2.4.3.2.Telehome t&n market
13.2.4.3.3.Telehospital/clinics t&n market
14.Chapter fourteen –Top ten medical device technologies patent analysis
14.1.General trends
15.Chapter fifteen - Company profiles
15.1.Abbott laboratories
15.1.1.Overview
15.1.2.Strategies and developments
15.2.Atrium medical corporation
15.2.1.Overview
15.2.2.Strategies and developments
15.3. Boston scientific
15.3.1.Overview
15.3.2.Strategies
15.3.3.Developments
15.4.Barosense, inc
15.4.1.Overview
15.5.Berchtold gmbh
15.5.1.Overview
15.5.2.Berchtold corporation product portfolio
15.6.Conor medsystems, llc
15.6.1.Overview
15.6.2.Strategies
15.6.3.Developments
15.7.Celonova biosciences inc
15.7.1.Overview
15.7.2.Product portfolio of celenova
15.7.3.Strategies
15.7.4.Developments
15.8.Ethicon endo-surgery
15.8.1.Overview
15.8.2.Strategies
15.9.Intromedic
15.9.1.Overview
15.9.2.Developments
15.10.Hitachi medical corporation
15.10.1.Overview
15.10.2.Strategy
15.10.3.Latest developments
15.11.Given imaging
15.11.1.Overview
15.11.2.Strategy
15.11.3.Developments
15.12.Ge medical systems
15.12.1.Overview
15.12.2.Proteus xr/a
15.12.3.Silhouette vr
15.12.4.Recent developments
15.13.Biomet, inc
15.13.1.Overview
15.13.2.Recent developments
15.14.Siemens medical solutions
15.14.1.Overview
15.14.2.Recent developments
15.15.Xtent, inc.
15.15.1.Overview
15.15.2.Recent developments
15.15.3.Product portfolio
15.16.Valleylab
15.16.1.Overview
15.17.Terumo medical corporation
15.17.1.Overview
15.17.2.Recent developments
15.18.Miv therapeutics, inc.
15.18.1.Overview
15.18.2.Recent developments
15.19.Orbusneich
15.19.1.Overview
15.19.2.Recent developments
15.20.Stentys s.a.s.
15.20.1.Overview
15.20.2.Recent developments
15.21.Medinol ltd.
15.21.1.Overview
15.21.2.Recent developments
15.22.Prosurgics
15.22.1.Overview
15.22.2.Recent developments
15.23.Roche
15.23.1.Overview
15.23.2.R&d innovations
15.23.3.Blockbuster products
15.24.Olympus
15.24.1.Overview
15.24.2.Recent developments
15.25.Medtronic, inc.
15.25.1.Overview
15.25.2.Recent developments
15.26.Scientific intake
15.26.1.Overview
15.26.2.Product
15.26.3.Overview
15.26.4.Recent developments
15.26.5.Product
15.27.Metacure nv
15.27.1.Overview
15.27.2.Developments
15.27.3.Product
15.28.Leptos biomedical, inc.
15.28.1.Overview
15.28.2.Technology
15.29.Hologic, inc.
15.29.1.Overview
15.30.Smith & nephew
15.30.1.Overview
15.30.2.Recent developments
15.30.3.Products
15.31.Integrated surgical systems inc (acquired by curexo technologies)
15.31.1.Overview
15.31.2.Recent developments
15.32.Allergan
15.32.1.Overview
15.32.2.Developments
15.33.Enteromedics
15.33.1.Overview
15.33.2.Recent developments
15.33.3.New products for enteromedics
15.34.Hélioscopie sa
15.34.1.Overview
15.35.Karl-storz
15.35.1.Recent developments
15.36.Esaote spa (a subsidiary of braco biomed spa)
15.36.1.Overview
15.36.2.Recent developments
15.37.Stryker
15.37.1.Overview
15.37.2.Recent developments
16.Chapter sixteen – appendix
16.1.U.s. Patents
16.2.European patents
16.3.Japanese patents
List of Tables
GLOBAL top ten device technologies MARKET 2007 – 2014 ($ MILLIONS)
GLOBAL DIAGNOSTIC IMAGING MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL DIAGNOSTIC IMAGING MARKET by geography THROUGH 2014 ($ Millions)
MERGERS AND ACQUISITIONS FOR DIAGNOSTIC IMAGING MARKET
NEW PRODUCT launch FOR DIAGNOSTIC IMAGING MARKET
GLOBAL MRI SYSTEMS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
MERGERS AND ACQUISITIONS FOR MRI MARKET
NEW PRODUCT LAUNCH FOR MRI MARKET
REGULARITY APPROVAL FOR MRI MARKET
OTHER DEVELOPMENTS FOR MRI MARKET
Global ULTRASOUND SYSTEMS market by geography THROUGH 2014 ($ Millions)
NEW PRODUCT LAUNCH FOR ULTRASOUND SYSTEMS MARKET
REGULAtory APPROVALs FOR ULTRASOUND SYSTEMS MARKET
Global X-RAY SYSTEMS market by geography THROUGH 2014 ($ Millions)
new product launch for X-RAY SYSTEMS
REGULARITY APPROVAL FOR X-RAY SYSTEMS
Global MAMMOGRAPHY EQUIPMENTS market by geography THROUGH 2014 ($ Millions)
MERGERS AND ACQUISITIONS FOR MAMMOGRAPHY EQUIPMENTS MARKET
NEW PRODUCT LAUNCH FOR MAMMOGRAPHY EQUIPMENTS MARKET
REGULATORY APPROVAL FOR MAMMOGRAPHY EQUIPMENTS MARKET
Global TORNOGRAPHY EQUIPMENTS market by geography THROUGH 2014 ($ Millions)
new product launch FOR TOMOGRAPHY EQUIPMENTS MARKET
REGULATORY APPROVAL FOR TOMOGRAPHY EQUIPMENTS MARKET
Global NUCLEAR IMAGING EQUIPMENTS market by geography THROUGH 2014 ($ Millions)
NEW PRODUCT LAUNCH FOR NUCLEAR IMAGING EQUIPMENTS MARKET
Global INTERVENTIONAL RADIOLOGY market by geography THROUGH 2014 ($ Millions)
NEW PRODUCT LAUNCH FOR INTERVENTIONAL RADIOLOGYS MARKET
Global CAPSULE ENDOSCOPY MARKET by geography THROUGH 2014 ($ Millions)
NEW PRODUCT LAUNCH FOR CAPSULE ENDOSCOPY MARKET
Global LASERS – IMAGING MAKRET by geography THROUGH 2014 ($ Millions)
GLOBAL DRUG DELIVERY DEVICES MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
Global DRUG DELIVERY DEVICES market by geography THROUGH 2014 ($ Millions)
Global INHALATION SYSTEMS market by Product THROUGH 2014 ($ Millions)
NEW PRODUCT LAUNCH FOR INHALATION SYSTEMS MARKET
REGULATORY APPROVAL FOR INHALATION SYSTEMS MARKET
Global INFUSION SYSTEM MARKET by geography THROUGH 2014 ($ Millions)
NEW PRODUCT LAUNCH FOR INFUSION SYSTEM MARKET
REGULATORY APPROVAL FOR INFUSION SYSTEM MARKET
other developments FOR INFUSION SYSTEMS MARKET
Global NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET by geography THROUGH 2014 ($ Millions)
REGULATORY APPROVAL FOR NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET
Global MEDICAL DIAGNOSTICS market by Product THROUGH 2014 ($ Millions)
GLOBAL MEDICAL DIAGNOSTICS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL BIOSENSORS MARKET BY geography THROUGH 2014 ($ MILLIONS)
NEW PRODUCT LAUNCH FOR BIOSENSOR MARKET
Global IVD market by geography THROUGH 2014 ($ Millions)
GLOBAL PROTEOMICS FOR MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPYH THROUGH 2014 ($ MILLIONS)
GLOBAL NANOTECHNOLOGY FOR MOLECULAR DIAGNOSTICS MARKET BY GEOGRAPYH THROUGH 2014 ($ MILLIONS)
REGULATORY APPROVAL FOR NANOTECHNOLOGY MARKET
GLOBAL PCR MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
NEW PRODUCT DEVELOPMENTS FOR PCR MARKET
GLOBAL ARRAYS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
MERGERS AND ACQUISITIONS FOR MOBILITY AID TECHNOLOGIES MARKET
GLOBAL POWERED WHEELCHAIRS DEVICES MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL SCOOTERS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL STAIR LIFTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL MANUAL WHEELCHAIRS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
NEW PRODUCT DEVELOPMENT FOR POWERED WHEELCHAIRS MARKET
NEW PRODUCT DEVELOPMENT FOR MANUAL WHEELCHAIRS MARKET
GLOBAL Mobility aid device MARKET BY technologY THROUGH 2014 ($ MILLIONS)
GLOBAL ROBOTICS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL NON-ROBOTICS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
Global Medical Robotics market by ProducT THROUGH 2014 ($ Millions)
Global Medical Robotics market by Geography THROUGH 2014 ($ Millions)
NEW PRODUCT DEVELOPMENt OF MEDICAL ROBOTICS
fda approvals for MEDICAL ROBOTICS
AGREEMENTS for MEDICAL ROBOTICS MARKET
mergers and acquisitions in MEDICAL ROBOTICS MARKET
partnerships in MEDICAL ROBOTICS MARKET
Global Lasers market by Geography THROUGH 2014 ($ Millions)
new product developments of lasers MARKET
FDA approval of laserS
AGREEMENTS for LASERS MARKET
Global market for obesity SURGERY MARKET BY geography Through 2014 ($ Millions)
GLOBAL MICRO-FLUIDS AND MEMS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL MICRO-FLUIDS AND MEMS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
Global Miniature Medical Pressure Sensors MARKET by GEOGRAPHY THROUGH 2014 ($ Millions)
GLOBAL BIOCHIPS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL BIOCHIPS BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
NEW PRODUCT DEVELOPMENTS FOR BIOCHIPS MARKET
GLOBAL DNA CHIPS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL DNA CHIPS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL PROTEIN CHIPS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
Global NON INVASIVE MONITORING market by Product THROUGH 2014 ($ Millions)
Global NON INVASIVE MONITORING market by GEOGRAPHY THROUGH 2014 ($ Millions)
Global NON INVASIVE BIOSENSORS market by Product THROUGH 2014 ($ Millions)
Global NON INVASIVE BIOSENSORS market by GEOGRAPHY THROUGH 2014 ($ Millions)
GLOBAL CONTINUOUS GLUCOSE MARKET MONITORING BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL BIOMATERIALS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL BIOMATERIALS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL BIONIC LIMBS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
NEW PRODUCT LAUNCH FOR BIONIC LIMBS MARKET
GLOBAL BIO-COMPATIBLE MATERIALS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL VULCANIZED SILICON BASED MATERIALS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL VULCANIZED SILICON BASED MATERIALS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL JOINT REPLACEMENT MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL ANTIMICROBIAL WOUND DRESSING MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
NEW PRODUCT LAUNCH FOR ANTIMICROBIAL WOUND DRESSING MARKET
REGULATORY APPROVAL FOR ANTIMICROBIAL WOUND DRESSING MARKET
GLOBAL BIOIMPLANTS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL BIOIMPLANTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL GRAFT BASED IMPLANTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
GLOBAL SYNTHETIC IMPLANTS MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL SYNTHETIC IMPLANTS MARKET BY GEOGRAPHY THROUGH 2014 ($ MILLIONS)
MERGERS AND ACQUISITIONS FOR DIAGNOSTIC IMAGING MARKET
NEW PRODUCT LAUNCH FOR SYNTHETIC IMPLANTS MARKET
REGULATORY APPROVAL FOR SYNTHETIC IMPLANTS MARKET
GLOBAL Neurostimulation MARKET BY PRODUCT THROUGH 2014 ($ MILLIONS)
GLOBAL Neurostimulation MARKET BY Geography THROUGH 2014 ($ MILLIONS)
GLOBAL Spinal cord stimulation MARKET BY Geography THROUGH 2014 ($ MILLIONS)
REGULATORY APPROVAL FOR VNS MARKET
TABLE X GLOBAL TELEMEDICINE TECHNOLOGY MARKET 2007 – 2014 ($ MILLIONS)
TELEMEDICINE HARDWARE MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLIONS)
Telemedicine software market forecast (Telehome and telehospital/clinics) 2007-2014 ($ MILLIONS)
Table 97 Number of Top ten medical device technologies PATENTS from 2004 to June 2009
ATRIUM MEDICAL CORPORATION PRODUCT PORTFOLIO
BOSTON SCIENTIFIC PRODUCT PORTFOLIO
CONOR MEDSYSTEMS PRODUCT PORTFOLIO
HITACHI MEDICAL CORPORATION Product portfolio
Given IMAGING Product portfolio
GE Medical Systems PRODUCT PORTFOLIO
Biomet PRODUCT PORTFOLIO
Siemens Healthcare PRODUCT PORTFOLIO
Table X Product Portfolio for Xtent, Inc.
Valleylab PRODUCT PORTFOLIO
Terumo Medical PRODUCT PORTFOLIO
MIV Therapeutics PRODUCT PORTFOLIO
OrbusNeich PRODUCT PORTFOLIO
Stentys PRODUCT PORTFOLIO
Medinol PRODUCT PORTFOLIO
Prosurgics PRODUCT PORTFOLIO
Roche PRODUCT PORTFOLIO
Medtronic PRODUCT PORTFOLIO
Smith & Nephew PRODUCT PORTFOLIO
Intuitive Surgical PRODUCT PORTFOLIO
Table X Pipeline Products for Allergan (present R&D status for obesity intervention)
Table X New Products for Allergan
Helioscopie PRODUCT PORTFOLIO
Karl Storz PRODUCT PORTFOLIO
Esaote PRODUCT PORTFOLIO
Stryker PRODUCT PORTFOLIO
List of Figure
Mapping the value chain of Medical device market
Global top ten medical device technologies market – revenue by categories
Market share vs market growth matrix for the top ten medical device technologies market *
Increasing share of older population in least developed regions
Telemedicine market drivers
Telemedicine - key to collaborative health care
Top ten medical device technologies patents filed For different geographies From 2004 to June 2009
Top ten medical device technologies patents filed Worldwide for different categories from 2004 to June 2009
Top ten medical device technologies patents filed in US From 2004 to June 2009
Top ten medical device technologies PATENTS filed in Europe From 2004 to June 2009
Top ten medical device technologies patents filed in Japan from 2004 to June 2009
Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care. This report identifies the sectors with the industry’s most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market.
IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014.
In 2009, the entire market for top ten medical device is estimated to be approximately $454.3 billion, of which medical diagnostic devices technologies alone constitute about 40% of the entire market at approximately $177.8 billion. The market for drug delivery devices constituted an estimated $110.8 billion for the same period.
The major driving factors in the home healthcare market is the patients’ drift towards a better quality of life, which has sped up the adoption of innovative medical devices; and has also accelerated IT integration in medical imaging and medical devices. However, the market opportunity for medical device technologies lies in the less developed countries.
Mobility aid technologies, micro-fluids and MEMS, tele-medicines and biomaterials are the fastest-growing medical device technologies at CAGRs of 20.7%, 19.7%, 14.2% and 12.9% respectively from 2009 to 2014. Of these, biomaterials shows huge potential because of its relatively bigger market size, with an estimated $46.6 billion in 2009 and $85.5 billion in 2014. The antimicrobial wound dressing segment is the fastest-growing biomaterials market, with an estimated size of $330 million in 2009 and $780 million in 2014.
Market estimates and forecast
The report provides in-depth market estimates and forecast for the top ten medical device technologies as follows:
Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
Bio-implants (neurostimulation and others)
Tele-medicines
Please fill in the form below to receive a sample copy of the report.
Custom Research
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
